FDA approves new HPV vaccine Cervarix for Girls – expands Gardasil Vaccine for Boys

October 17, 2009

(ChattahBox) — The US Food and Drug Administration has approved a bivalent [recombinant] human papillomavirus (HPV) vaccine Cervarix by GlaxoSmithKline for the prevention of cervical cancer and precancers caused by HPV types 16 and 18 for use in girls and young women ages 10-25 to help prevent cervical cancer.  In clinical trials, Cervarix was shown to be 93% effective in preventing cervical precancers associated with HPV 16 or HPV18 in women with no evidence of current or previous infection with one of those two HPV types, according to GlaxoSmithKline.  Cervarix is the second FDA-approved HPV vaccine. In June 2006, the FDA approved the first HPV vaccine, Merck’s Gardasil, which targets four strains of HPV: HPV 6, HPV 11, HPV 16, and HPV 18.

The FDA also just approved Gardasil  a vaccine already used to prevent cervical cancer in women, for use in boys and men ages 9-26. Today’s approval was for using the vaccine to prevent genital warts, which are also caused by HPV.  The vaccine is given in three doses, at $130 per dose , a price that may seem a bit high for reducing the risk of getting warts, but it might also reduce the risk that unvaccinated girls would get HPV.


Comments

One Response to “FDA approves new HPV vaccine Cervarix for Girls – expands Gardasil Vaccine for Boys”

  1. FDA approves new HPV vaccine Cervarix for Girls – expands Gardasil … | girls on October 17th, 2009 1:39 pm

    […] Read more here: FDA approves new HPV vaccine Cervarix for Girls – expands Gardasil … […]

Got something to say? **Please Note** - Comments may be edited for clarity or obscenity, and all comments are published at the discretion of ChattahBox.com - Comments are the opinions of the individuals leaving them, and not of ChattahBox.com or its partners. - Please do not spam or submit comments that use copyright materials, hearsay or are based on reports where the supposed fact or quote is not a matter of public knowledge are also not permitted.